Letter: anti-TNF therapy and intestinal resections in Crohn's disease-are we just delaying the inevitable?

被引:3
作者
Ashton, James J. [1 ,2 ]
Beattie, R. Mark [1 ]
机构
[1] Southampton Childrens Hosp, Dept Paediat Gastroenterol, Southampton, Hants, England
[2] Univ Southampton, Dept Human Genet & Genom, Southampton, Hants, England
关键词
D O I
10.1111/apt.15482
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:842 / 843
页数:2
相关论文
共 9 条
[1]   Increased prevalence of anti-TNF therapy in paediatric inflammatory bowel disease is associated with a decline in surgical resections during childhood [J].
Ashton, James J. ;
Borca, Florina ;
Mossotto, Enrico ;
Coelho, Tracy ;
Batra, Akshay ;
Afzal, Nadeem A. ;
Phan, Hang T. T. ;
Stanton, Michael ;
Ennis, Sarah ;
Beattie, Robert Mark .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 49 (04) :398-407
[2]   Surgery for children with Crohn's disease: indications, complications and outcome [J].
Blackburn, S. C. ;
Wiskin, A. E. ;
Barnes, C. ;
Dick, K. ;
Afzal, N. A. ;
Griffiths, D. M. ;
Beattie, R. M. ;
Stanton, M. P. .
ARCHIVES OF DISEASE IN CHILDHOOD, 2014, 99 (05) :420-426
[3]   Anti-TNF treatment in Crohn's disease and risk of bowel resection-a population based cohort study [J].
Eberhardson, M. ;
Soderling, J. K. ;
Neovius, M. ;
Cars, T. ;
Myrelid, P. ;
Ludvigsson, J. F. ;
Askling, J. ;
Ekbom, A. ;
Olen, O. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (06) :589-598
[4]   Small molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signaling [J].
Hrdinka, Matous ;
Schlicher, Lisa ;
Dai, Bing ;
Pinkas, Daniel M. ;
Bufton, Joshua C. ;
Picaud, Sarah ;
Ward, Jennifer A. ;
Rogers, Catherine ;
Suebsuwong, Chalada ;
Nikhar, Sameer ;
Cuny, Gregory D. ;
Huber, Kilian V. M. ;
Filippakopoulos, Panagis ;
Bullock, Alex N. ;
Degterev, Alexei ;
Gyrd-Hansen, Mads .
EMBO JOURNAL, 2018, 37 (17)
[5]   Mechanism of Action of Anti-TNF Therapy in Inflammatory Bowel Disease [J].
Levin, Alon D. ;
Wildenberg, Manon E. ;
van den Brink, Gijs R. .
JOURNAL OF CROHNS & COLITIS, 2016, 10 (08) :989-997
[6]   Changes in Disease Behaviour and Location in Patients With Crohn's Disease After Seven Years of Follow-Up: A Danish Population-based Inception Cohort [J].
Lo, B. ;
Vester-Andersen, M. K. ;
Vind, I. ;
Prosberg, M. ;
Dubinsky, M. ;
Siegel, C. A. ;
Bendtsen, F. ;
Burisch, J. .
JOURNAL OF CROHNS & COLITIS, 2018, 12 (03) :265-272
[7]   Introduction of anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases: a population-based interrupted time series study [J].
Murthy, Sanjay K. ;
Begum, Jahanara ;
Benchimol, Eric, I ;
Bernstein, Charles N. ;
Kaplan, Gilaad G. ;
McCurdy, Jeffrey D. ;
Singh, Harminder ;
Targownik, Laura ;
Taljaard, Monica .
GUT, 2020, 69 (02) :274-282
[8]   Early anti-TNF/immunomodulator therapy is associated with better long-term clinical outcomes in Asian patients with Crohn's disease with poor prognostic factors [J].
Oh, Eun Hye ;
Oh, Kyunghwan ;
Han, Minkyu ;
Seo, Hyungil ;
Chang, Kiju ;
Lee, Sun-Ho ;
Kim, Gwang-Un ;
Song, Eun Mi ;
Seo, Myeongsook ;
Lee, Ho-Su ;
Hwang, Sung Wook ;
Park, Sang Hyoung ;
Yang, Dong-Hoon ;
Kim, Kyung-Jo ;
Byeon, Jeong-Sik ;
Myung, Seung-Jae ;
Yang, Suk-Kyun ;
Ye, Byong Duk .
PLOS ONE, 2017, 12 (05)
[9]   Genetic influences on the Development of Fibrosis in Crohn's Disease [J].
Verstockt, Bram ;
Cleynen, Isabelle .
FRONTIERS IN MEDICINE, 2016, 3